# SABBY MANAGEMENT, LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1535610. Source: https://holderbook.com/funds/1535610-sabby-management-llc/

- Reported value: $110.5M
- Positions: 23
- Weight of the ten largest: 96.9%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| STATE STR SPDR S&P 500 ETF T | [SPY](https://holderbook.com/stocks/SPY/) | $54.1M | 0 | 49.0% | 17 |
| STATE STR SPDR S&P 500 ETF T | [SPY](https://holderbook.com/stocks/SPY/) | $15.3M | 0 | 13.9% | 1 |
| ISHARES TR | [IWM](https://holderbook.com/stocks/IWM/) | $13.3M | 0 | 12.0% | 1 |
| ISHARES TR | [IWM](https://holderbook.com/stocks/IWM/) | $13.2M | 0 | 12.0% | 26 |
| STATE STR SPDR S&P 500 ETF T | [SPY](https://holderbook.com/stocks/SPY/) | $4.1M | 5,500 | 3.7% | 3 |
| TOYO CO LTD | [TOYO](https://holderbook.com/stocks/TOYO/) | $3.5M | 503,846 | 3.2% | 1 |
| ABIVAX SA | [ABVX](https://holderbook.com/stocks/ABVX/) | $1.1M | 0 | 1.0% | 3 |
| FARMMI INC | [FAMI](https://holderbook.com/stocks/FAMI/) | $840.3K | 3,515,929 | 0.8% | 1 |
| SIDUS SPACE INC | [SIDU](https://holderbook.com/stocks/SIDU/) | $816.3K | 0 | 0.7% | 2 |
| CERVOMED INC | [CRVO](https://holderbook.com/stocks/CRVO/) | $771.5K | 248,880 | 0.7% | 1 |
| ZEVRA THERAPEUTICS INC | [ZVRA](https://holderbook.com/stocks/ZVRA/) | $612.3K | 0 | 0.6% | 7 |
| TEMPEST THERAPEUTICS INC | [TPST](https://holderbook.com/stocks/TPST/) | $567.5K | 511,286 | 0.5% | 3 |
| PARANOVUS ENTERTNMNT TECH LT | - | $560.5K | 75,440 | 0.5% | 1 |
| BIOAFFINITY TECHNOLOGIES INC | [BIAF](https://holderbook.com/stocks/BIAF/) | $296.9K | 365,647 | 0.3% | 1 |
| SMART POWERR CORP | - | $263.2K | 127,774 | 0.2% | 1 |
| BRIACELL THERAPEUTICS CORP | [BCTX](https://holderbook.com/stocks/BCTX/) | $261.5K | 80,721 | 0.2% | 2 |
| REVELATION BIOSCIENCES INC | [REVB](https://holderbook.com/stocks/REVB/) | $216.9K | 210,582 | 0.2% | 2 |
| SENESTECH INC | [SNES](https://holderbook.com/stocks/SNES/) | $211.2K | 141,756 | 0.2% | 4 |
| BRIACELL THERAPEUTICS CORP | [BCTXL](https://holderbook.com/stocks/BCTXL/) | $169.4K | 190,383 | 0.2% | 2 |
| SIDUS SPACE INC | [SIDU](https://holderbook.com/stocks/SIDU/) | $121.9K | 43,377 | 0.1% | 1 |
| INMED PHARMACEUTICALS INC | [INM](https://holderbook.com/stocks/INM/) | $69.7K | 44,970 | 0.1% | 4 |
| NUWELLIS INC | - | $49.9K | 16,372 | 0.0% | 1 |
| BRIACELL THERAPEUTICS CORP | [BCTXZ](https://holderbook.com/stocks/BCTXZ/) | $11.5K | 120,802 | 0.0% | 5 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | -3.3% | +14.8% | -18.1% | 83% |
| Q1 2026 | -17.2% | -4.6% | -12.6% | 64% |
| Q3 2025 | +27.3% | +7.8% | +19.5% | 79% |
| Q2 2025 | +30.0% | +10.5% | +19.5% | 92% |
| Q1 2025 | -20.6% | -4.6% | -16.0% | 97% |
| Q4 2024 | -6.4% | +2.1% | -8.5% | 76% |
| Q3 2024 | +2.7% | +5.4% | -2.7% | 81% |
| Q2 2024 | -23.0% | +4.0% | -27.0% | 72% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $110.5M | 23 |
| Q1 2026 | $45.1M | 28 |
| Q4 2025 | $69.5M | 33 |
| Q3 2025 | $86.4M | 39 |
| Q2 2025 | $55.1M | 43 |
| Q1 2025 | $34.0M | 46 |
| Q4 2024 | $76.9M | 27 |
| Q3 2024 | $186.4M | 42 |
| Q2 2024 | $148.7M | 39 |
| Q1 2024 | $173.3M | 55 |
| Q4 2023 | $100.0M | 56 |
| Q3 2023 | $136.6M | 84 |